Clinical trials
Completed Alcoholism trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Technische Universität Dresden | 10 |
| Central Institute of Mental Health, Mannheim | 7 |
| Charite University, Berlin, Germany | 7 |
| University of Konstanz | 3 |
| H. Lundbeck A/S | 2 |
| Heinrich-Heine University, Duesseldorf | 1 |
| Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | 1 |
| Ludwig-Maximilians - University of Munich | 1 |
| Novartis Pharmaceuticals | 1 |
| Salus Klinik Lindow | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcoholism | 37 |
| Fractures, Stress | 2 |
| Tobacco Use Disorder | 2 |
| Alcohol-Related Disorders | 1 |
| Anxiety Disorders | 1 |
| Depressive Disorder | 1 |
| Liver Cirrhosis | 1 |
| Mental Disorders | 1 |
| Psychological Trauma | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.